Advanced search
Publication Cover
Hematology Volume 27, 2022 - Issue 1
Submit an article Journal homepage
3,956
Views
0
CrossRef citations to date
0
Altmetric
Rapid Communication

AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcome

Nada Assafa Department of Pathology and Laboratory Medicine, Cytogenetics division, American University of Beirut Medical Center, Beirut, LebanonCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3352-2660
ORCID Icon,
Christine Lefebvreb Laboratoire d’Hématologie Biologique, Centre Hospitalier Universitaire de Grenoble Alpes (CHUGA), La Tronche, France
,
Victoria Raggueneauc Department of Laboratory Medicine, Hematology, Centre Hospitalier de Versailles, Le Chesnay, France
,
Geoffroy Guignedouxd Laboratoire d’Hématologie, Centre Hospitalier René Dubos Pontoise, Pontoise, France
,
Alice Marceau-Renaute University of Lille, CNRS, Inserm, CHU Lille, Institut de Recherche contre le Cancer de Lille, UMR9020–UMR-S 1277—Canther—Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France
,
Simon Chevalierb Laboratoire d’Hématologie Biologique, Centre Hospitalier Universitaire de Grenoble Alpes (CHUGA), La Tronche, France
,
Sylvie Tondeurb Laboratoire d’Hématologie Biologique, Centre Hospitalier Universitaire de Grenoble Alpes (CHUGA), La Tronche, France
,
Dominique Boriesf Department of Molecular Onco-Hematology Henri Mondor Hospital (APHP-UPEC), Créteil, France
,
Riad Benramdaned Laboratoire d’Hématologie, Centre Hospitalier René Dubos Pontoise, Pontoise, France
,
Philippe Rousselotg Department of Hematology, Centre Hospitalier de Versailles, France & University Paris-Saclay, UMR1184, Le Chesnay, France
&
Christine Terréh Department of Laboratory Medicine, Hemato-Oncologic Cytogenetics, Centre Hospitalier de Versailles, Le Chesnay, France
 show all
Pages 636-641 | Published online: 27 May 2022

References

  • Schoch C, Kern W, Schnittger S, et al. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups. Haematologica. 2004 Sep;89(9):1082–1090.
  • Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Vol. 2. International agency for research on cancer Lyon, France; 2008.
  • Han SY, Mrózek K, Voutsinas J, et al. Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21). Blood Adv. 2021 May 25;5(10):2481–2489.
  • Appelbaum FR, Kopecky KJ, Tallman MS, et al. The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations. Br J Haematol. 2006 Oct;135(2):165–173.
  • Mosna F, Papayannidis C, Martinelli G, et al. Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up. Am J Hematol. 2015 Jun;90(6):515–523.
  • Ducourneau B, Fenwarth L, Duployez N, et al. Cytogenetically masked CBFB-MYH11 fusion and concomitant TP53 deletion in a case of acute myeloid leukemia with a complex karyotype. Leuk Lymphoma. 2020 Jul;61(7):1772–1774.
  • Nakaya A, Fujita H, Tachibana T, et al. [Complex additional chromosomal abnormalities of del(5q), del(7q), and +22 in a patient with acute myelomonocytic leukemia carrying inv(16)]. Rinsho Ketsueki. 2004 Sep;45(9):1061–1063.
  • Ida T, Hashimoto S, Yano T, et al. [Additional chromosomal abnormality of inv(16)(p13q22) to del(7)(q32) in a patient with acute myelomonocytic leukemia]. Rinsho Ketsueki. 2012 Mar;53(3):347–351.
  • Hasle H, Alonzo TA, Auvrignon A, et al. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood. 2007 Jun 1;109(11):4641–4647.
  • Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017 Jan 26;129(4):424–447.
  • Kuykendall A, Duployez N, Boissel N, et al. Acute Myeloid Leukemia: The Good, the Bad, and the Ugly. Am Soc Clin Oncol Educ Book. 2018 May 23;38:555–573.
  • Schwind S, Edwards CG, Nicolet D, et al.. inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations. Blood. 2013 Jan 10;121(2):385–391.
  • Schnittger S, Bacher U, Haferlach C, et al. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients. Leukemia. 2007 Apr;21(4):725–731.
  • Andersen MK, Johansson B, Larsen SO, et al. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements. Haematologica. 1998 Jun;83(6):483–488.
  • Andersen MK, Larson RA, Mauritzson N, et al. Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: Report from an International Workshop†. Genes. Chromosomes and Cancer. 2002;33(4):395–400.
  • Ganser A, Heuser M. Therapy-related myeloid neoplasms. Curr Opin Hematol. 2017 Mar;24(2):152–158.
  • Herold T, Rothenberg-Thurley M, Grunwald VV, et al. Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia. Leukemia. 2020 Dec;34(12):3161–3172.
  • Rogers HJ, Wang X, Xie Y, et al. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study. Am J Hematol. 2020 Jul;95(7):799–808.
  • Stölzel F, Mohr B, Kramer M, et al. Karyotype complexity and prognosis in acute myeloid leukemia. Blood Cancer J. 2016 Jan 15;6(1):e386.
  • Byrd JC, Mrózek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002 Dec 15;100(13):4325–4336.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.